Amino-oxyacetate (carboxymethoxylamine) was found to inhibit protein labelling in isolated liver cells. A similar degree of inhibition (about 7000) was observed of basal and substrate-stimulated rates of protein labelling, ruling out an action on the cellular energy state. Its effect does not seem to be related either to a perturbation of the reduction state of the NAD system or to rate changes in the gluconeogenic pathway. The following observations indicate that amino-oxyacetate inhibits protein labelling by limiting aspartate supply.
INTRODUCTION
Amino-oxyacetate (carboxymethoxylamine), a wellcharacterized inhibitor of pyridoxal-dependent enzymes [1, 2] , has also been described to be an effective inhibitor of protein synthesis in liver cells [3, 4] . Amino-oxyacetate also displays a wide variety of metabolic inhibitory effects in liver. A shift of the cytosolic NAD system to a more reduced state [5] , probably secondary to an inhibition of the malate-aspartate shuttle [1, [5] [6] [7] [8] , seems to be a primary effect of amino-oxyacetate, leading to the perturbation of other metabolic pathways [1, 8] . The state of reduction of the NAD system has been claimed to influence protein synthesis [9] . Thus amino-oxyacetate offered a unique tool with which to explore this possibility further. Our current work is an attempt to elucidate the mechanisms implicated in the inhibition of liver protein synthesis by amino-oxyacetate. We have considered two possibilities: (a) that this inhibitor acted directly, competing with some amino acid or limiting some pyridoxal-dependent reaction involved in protein synthesis; (b) an indirect mechanism could be a perturbation of other metabolic pathways, leading to changes in nucleotide content and/or the availability of some limiting amino acids. Our results seem to indicate that amino-oxyacetate exerts its inhibitory effect on liver cells primarily by limiting aspartate availability. 
.). Isolation and incubation of rat liver cells
The procedure for isolation of liver cells was described previously [4] . The cells were incubated in Krebs-Ringer bicarbonate buffer containing 2% Ficoll 70. The pH of the incubation mixture was 7.4 after equilibration with 02/CO2 (19: 1). Determination of protein-synthesis activity L-[U-3H]Valine was utilized as the amino acid precursor, since it is poorly oxidized or transaminated by the liver cells [10] . Routinely, 1 ml portions of liver cells (40-60 mg wet wt./ml) were placed in plastic 25 ml Erlenmeyer flasks and incubated at 36.5°C in a rotary shaker. The incubation medium contained 0.5 mM-L-[3H]valine (sp. radioactivity 10 Ci/mol). This concentration seems to be close to saturation [4] , thus minor changes in the size of the valine pool utilized for protein synthesis would not induce appreciable changes in the rate of protein labelling. At the end of the experiment, triplicate samples (0.1 ml) were immediately added to cold 10% trichloroacetic acid and processed as described previously [4] . Determination of the gluconeogenic rate and state of reduction of the NAD system For these determinations, the cell incubation medium contained 1.5% gelatin instead of Ficoll 70, which is hydrolysed at low pH, yielding free glucose. Routinely 2-3 ml of cell suspension (40-60 mg wet wt./ml) was incubated in plastic 25 ml Erlenmeyer flasks at 36.5°C with constant rotary shaking; portions (1 ml) of the cell suspensions were taken after 1 h of incubation and immediately acidified with cold HCl04 (final concn. 7 %, v/v). The precipitate was sedimented by centrifugation at 13000 rev./min for 2 min in an Eppendorf microcentrifuge and the supernatant neutralized to pH 7.0 with 3 M-KOH containing 0.5 M-triethanolamine. The samples were centrifuged at 13000 rev./min for 2 min, and glucose, lactate and pyruvate were determined by previously described enzymic procedures [11] . Determination of the intracellular amino acid content of the liver cells For this determination 2 For these experiments, small liver biopsies were taken from anaesthetized rats. Postmitochondrial supernatants were prepared as described previously [12] .
The incubation mixture (final volume 0.5 ml) contained: 2 mM-ATP, 0.8 mM-GTP, 3 After incubation at 37°C for 5 min, 100 u1 samples were taken; 2 ml of 10% trichloroacetic acid and 1 mg of bovine serum albumin were then added to each. After heating at 90°C for 15 min, the samples were filtered through Millipore membranes, each sample being washed with 5 x 2 ml of 500 trichloroacetic acid each time. The filters were dried and placed in vials with 15 ml of a toluene/2,5-diphenyloxazole mixture.
The protein content of the postmitochondrial supernatants was determined by the Lowry method [13] .
The glutamyl-tRNA synthetase activity was determined in pH 5 supernatants obtained from rat liver as previously described [14] . The reaction mixture ( The aspartyl-tRNA synthetase activity of liver extract was determined in the 150000 g pellet obtained as described by Geels et al. [15] Under our experimental conditions, with protein-and amino-acid-free incubation medium, the concentration of amino-oxyacetate required to produce 50 o inhibition is about 20 /tM. This observation contrasts with the 2 mM concentration described by Seglen et al. [3] . A non-specific binding of the inhibitor to some of the incubationmedium components, perhaps albumin, or the competitive action of some of the metabolites with which the medium was supplemented, might explain the difference. Our observation that amino-oxyacetate is fully effective in inhibiting protein labelling in micromolar concentrations is more in accordance with the reported Ki for aspartate and other aminotransferases [16] and also with the concentrations described to lead to several metabolic perturbations [1, [4] [5] [6] [7] . Thus our results suggest that the inhibition of protein labelling by amino-oxyacetate may be related to its ability to decrease flux through certain key aminotransferases. Further support forthisinterpretation may be found in Table 1 , which illustrates the reversibility of the amino-oxyacetate action on protein labelling by a mixture of amino acids. Although these data point to the participation ofsome amino-oxyacetatesensitive aminotransferase reaction in its effect inhibiting protein labelling, it cannot be discemed whether its action Since the presence of an amino acid mixture prevented the effect of amino-oxyacetate on protein labelling (Table  1) , it was decided to determine whether specific individual amino acids related to the aspartate aminotransferase reaction were effective, or whether it was a non-specific effect related to substrate supply and/or increased energy production. According to data in Table  2 , only proline, glutamine and asparagine were effective in increasing the rate of protein labelling in the presence of amino-oxyacetate. These amino acids share the capacity to increase the intracellular concentration of glutamate and/or aspartate [17] [18] [19] . Since the inhibitory effect of amino-oxyacetate on aspartate aminotransferase is a function of the concentration of those two amino acids when tested in the isolated purified enzyme as well as in the intact cell [20] , the results in Table 2 seem to indicate that normal flux through aspartate aminotransferase is required in order to maintain normal rates of protein labelling. The lack of response to aspartate is not surprising, in view of the low rate of metabolic conversion of this amino acid [21] , which indicates that its permeability across the plasma membrane is highly restricted. Thus, at the concentration of the amino acid used in these experiments, its rate of metabolic conversion seems to be similar to the rate of transport, resulting in no detectable changes in the cytosolic steady-state concentration. Relationship between metabolic perturbations induced by amino-oxyacetate and its effect on protein labelling
When amino-oxyacetate was tested on a liver postmitochondrial supernatant, no detectable effects were observed on rates of protein labelling (results not shown). This finding suggests that, by whatever mechanism its action is mediated, it does not involve a direct interaction with the protein-synthesis machinery. Furthermore, amino-oxyacetate was not able to inhibit glutamylor aspartyl-tRNA synthetase when assayed at a concentration of 0.2 mm in the presence of tracer amounts of the amino acid (results not shown).
On these grounds, it was decided to study whether the effect on protein synthesis was related to the metabolic perturbations induced by the inhibitor. For this purpose a comparative study with the action of cycloserine, another inhibitor of pyridoxal-dependent reactions [22] [23] [24] [25] [26] [27] , was carried out. Fig. 2 shows the striking difference between the effect of both aminotransferase inhibitors on protein labelling in liver cells in the presence of gluconeogenic precursors of different reduction states. Although amino-oxyacetate was effective regardless of the substrate utilized, extremely large concentrations of cycloserine were required to inhibit protein labelling only in the presence of lactate. The latter effect, in view of the concentrations of cycloserine required, several orders of magnitude above the reported Ki for the aminotransferase [26] , can probably be explained by taking into account the reported action of cycloserine in decreasing pyruvate availability [28] . The differential effect of these two inhibitors on protein synthesis cannot be explained on the basis of a lack of permeability of the mitochondrial membrane towards L-cycloserine, since it has been shown that L-cycloserine effectively inhibits alanine metabolism in isolated mitochondria [29] . Alternative explanations could be that L-cycloserine is a less effective inhibitor of aspartate aminotransferase than is amino-oxyacetate [7, 29] , or transaminase activity is not essential for protein synthesis.
The inhibition of the malate-aspartate shuttle by aminotransferase inhibitors leads to a more reduced cytosolic NAD system and inhibition of gluconeogenesis from reduced precursors such as lactate [6, 7, 30, 31] shown in Fig. 2 The lack ofcorrelation between the observed metabolic perturbations and the effect on protein labelling allows us to conclude that those parameters are not involved in the amino-oxyacetate action. The observation that normal rates of gluconeogenesis can be attained (Fig. 3) in the presence of amino-oxyacetate rules out the possibility that the observed inhibition of protein labelling could be the result ofa perturbation ofcellular energy metabolism. This conclusion is also supported by reports indicating that amino-oxyacetate does not induce detectable changes in the rate of cellular oxygen uptake [5] or ATP content [7] . Correlation between cellular amino acid content and ability of amino-oxyacetate to inhibit protein labelling
The evidence presented so far seems to suggest that some event dependent on flux through aspartate aminotransferase is responsible for the inhibitory effect of amino-oxyacetate on protein labelling. However, the observation that amino-oxyacetate had no effect on protein labelling in a postmitochondrial supernatant in the presence of unlimiting supply of amino acids, considering also the lack of effect of L-cycloserine in intact cells, clearly indicates that amino-oxyacetate does not act directly on the protein-synthesis machinery, but probably indirectly by limiting amino acid supply. Two observations strongly suggest that it is not the overall amino acid supply, but the availability of some key amino acid reactant of the aspartate aminotransferase, that may be limiting in the presence of amino-oxyacetate.
First, the measurement of the intracellular concentration of amino acids indicates that most of them, the only exceptions being aspartate and the aromatics, accumulated in the presence of amino-oxyacetate (Table 3) . Second, the inhibitory effects of amino-oxyacetate were overcome by the addition of single amino acids whose metabolism leads to glutamate and/or aspartate formation (Table 2 and Fig. 5 ). These data strongly suggest that the decrease in aspartate availability might play an important role in the amino-oxyacetate action. On these grounds, it was decided to determine the effect of amino-oxyacetate on the cellular concentration of aspartate and glutamate under several incubation conditions. The results are summarized in Table 4 . The interest of these data is threefold: first, in contrast with amino-oxyacetate, L-cycloserine had no effect in decreasing aspartate concentration; second, in the presence of asparagine, glutamine or proline, amino acids that effectively reversed the amino-oxyacetate-induced inhibition (Table 4) , glutamate and aspartate concentrations were significantly increased, and amino-oxyacetate either had no effect in decreasing aspartate, or, if it did, the concentration remained above the basal control value; third, ornithine and histidine induced a significant [32] .
The intracellular distribution of aspartate has been a subject of controversy. Mitochondrial/cytosolic gradients from 0.2 to well above unity have been described [33, 34] . Assuming an even distribution of aspartate and cytosolic and mitochondrial water contents of 2.0 and 0.2 ml/g dry wt. [35] , then the cytosolic aspartate concentration reached in our experiments would be 0.7 mm. Although high Km values for aspartate have been reported for certain aspartyl-tRNA synthetases [36] , in mammalian tissues the Km for amino acids of the aminoacyl-tRNA synthetases seems to be in the micromolar range [37] . Actually, under our experimental conditions the Km for aspartyl-tRNA synthetase was below 100 /M (results not shown). Thus the observation that a decrease in cytosolic aspartate below 0.7 mM causes a decreased rate of protein labelling under conditions under which -all other amino acids accumulate suggests the following explanations: first, the Km for aspartate of the isolated aspartyl-tRNA synthetase differs from that Control (8) Asparagine (4) Proline (4) Glutamine (5) Ornithine (4) Histidine ( 
